Roy Baynes

Roy Baynes

Directeur/Membre du Conseil chez TRAVERE THERAPEUTICS, INC.

Fortune : 2 M $ au 30/06/2024

69 ans
Health Technology
Commercial Services
Health Services

Profil

Roy D.
Baynes
is currently serving as the Chief Medical Officer & Executive Vice President at Eikon Therapeutics, Inc. He is also an Independent Director at Natera, Inc., Travere Therapeutics, Inc., and CatalYm GmbH.
Additionally, he holds memberships in the American Society of Clinical Oncology, Inc., the American Association for Cancer Research, and the American Society of Hematology.
Previously, Dr. Baynes served as an Independent Director at Atara Biotherapeutics, Inc. from 2018 to 2022.
He was the VP-Global Development & Head-Hematology Oncology at Amgen, Inc. from 2002 to 2012.
From 2012 to 2013, he held the position of SVP-Oncology, Inflammation & Respiratory at Gilead Sciences, Inc. He also served as the Chief Medical Officer at Merck & Co., Inc. and as the SVP & Head-Global Clinical Development at Merck Research Laboratories Massachusetts LLC from 2013 to 2022.
Additionally, he worked as a Professor at the Barbara Ann Karmanos Cancer Institute.
Dr. Baynes obtained his graduate degree in 1973 and his doctorate degree in 1985 from the University of the Witwatersrand.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/06/2024 15 540 ( 0,01% ) 2 M $ 30/06/2024
08/05/2024 31 000 ( 0,04% ) 254 820 $ 30/06/2024

Postes actifs de Roy Baynes

SociétésPosteDébut
TRAVERE THERAPEUTICS, INC. Directeur/Membre du Conseil 01/07/2016
NATERA, INC. Directeur/Membre du Conseil 25/07/2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur Technique/Scientifique/R&D 01/07/2022
Directeur/Membre du Conseil -
Tous les postes actifs de Roy Baynes

Anciens postes connus de Roy Baynes

SociétésPosteFin
ATARA BIOTHERAPEUTICS, INC. Directeur/Membre du Conseil 19/12/2022
Directeur Technique/Scientifique/R&D 01/04/2022
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Roy Baynes

Formation de Roy Baynes

University of the Witwatersrand Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Roy Baynes

Relations

100 +

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
AMGEN INC.

Health Technology

GILEAD SCIENCES, INC.

Health Technology

TRAVERE THERAPEUTICS, INC.

Health Technology

MERCK & CO., INC.

Health Technology

NATERA, INC.

Health Technology

ATARA BIOTHERAPEUTICS, INC.

Health Technology

Entreprise privées7

Health Technology

Health Services

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Roy Baynes